Comparative Pharmacology
Head-to-head clinical analysis: OSMITROL 15 IN WATER versus OSMITROL 5 IN WATER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: OSMITROL 15 IN WATER versus OSMITROL 5 IN WATER.
OSMITROL 15% IN WATER vs OSMITROL 5% IN WATER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Osmotic diuretic; increases plasma osmolality, drawing water from extravascular to intravascular space, thereby reducing intracranial and intraocular pressure.
Osmotic diuretic that increases plasma osmolality, drawing water from intracellular and interstitial spaces into the extracellular compartment, thereby reducing cerebral edema and intraocular pressure; also promotes diuresis by increasing renal tubular fluid osmolality.
IV infusion of 50-200 g over 30-60 minutes as a 15% solution; typical adult dose is 1.5-2 g/kg every 6-8 hours.
50-100 g intravenously as a 5% solution over 30-60 minutes; may repeat every 6-8 hours as needed. Maximum dose: 200 g in 24 hours.
None Documented
None Documented
Terminal elimination half-life is approximately 0.25–1.5 hours in patients with normal renal function; prolonged to 24–36 hours in anuria or severe renal impairment.
Approximately 0.25-1.5 hours (15-90 minutes); prolonged in renal impairment or with mannitol accumulation (e.g., in anuria).
Primarily renal excretion as unchanged drug; >97% eliminated by glomerular filtration within 24 hours. Minimal biliary/fecal elimination (<3%).
Primarily renal (90-100% unchanged in urine); negligible biliary or fecal elimination.
Category C
Category C
Osmotic Diuretic
Osmotic Diuretic